Chin Filler Craze – FDA Flags Risks

Tree shaped like a human head with leaves turning brown and falling — Photo: Lightspring / Shutterstock

Chin filler has become one of the fastest-growing requests in cosmetic medicine, with patients choosing a quick injection over surgery to fix a weak or uneven jawline.

Quick Take

Dermal fillers rank as the second most common minimally invasive cosmetic procedure in the United States, with about 2.7 million treatments done each year.
Chin-specific fillers like JUVÉDERM VOLUMA XC and VOLUX can add volume, sharpen the jawline, and reduce sagging for up to two years per treatment.
Surgical chin augmentation dropped nearly 17% in recent years as more patients switch to non-surgical options.
Patient satisfaction studies show high approval rates, but the Food and Drug Administration (FDA) also tracks real risks tied to improper injection.

Demand For Chin Filler Keeps Rising

Cosmetic clinics across the country report growing interest in chin and lower-face filler treatments. The FDA says dermal fillers are now the second most common minimally invasive cosmetic procedure in the United States, with roughly 2.7 million treatments performed every year. That demand kept growing in 2024, with both hyaluronic acid and non-hyaluronic acid filler procedures showing continued increases, according to FDA safety briefing materials.

Providers like Weiler Plastic Surgery Group market specific products for the chin and jaw area. JUVÉDERM VOLUMA XC is advertised to volumize, lift, and contour the cheeks, chin, jawline, and temples, while VOLUX targets the jawline and chin to add definition and reduce jowling. Results from these treatments can last up to two years, with starting prices around $900 at some practices.

What The Treatment Actually Does

Chin filler works by injecting a gel-like substance, usually hyaluronic acid, under the skin to build volume and shift the shape of the lower face. Researchers note that non-surgical chin and jawline treatments are becoming more popular because they are temporary, do not require cutting into the skin, and still produce visible, effective results for many patients.

A systematic review of nearly 1,000 patients who got hyaluronic acid chin treatments found most reported being satisfied with their results. The same research called hyaluronic acid filler a proven and safe alternative to surgical chin augmentation for many candidates.

Why Patients Are Skipping Surgery

Surgical chin augmentation, which includes bone-cutting procedures and permanent implants, still delivers long-lasting results and strong patient satisfaction, according to a comparison of surgical and non-surgical techniques. But that same research points to a clear trend: demand for surgical chin procedures fell by almost 17 percent in recent years, as more people choose injections that need no recovery time, no incisions, and no general anesthesia.

The appeal goes beyond convenience. A review of hundreds of chin filler patients found most achieved noticeable improvement with a single treatment, and researchers pointed to high satisfaction combined with low complication rates as key reasons injectables keep gaining ground over the operating room.

Risks Patients Should Understand

Fillers are not risk-free. The FDA lists bruising, redness, swelling, and pain as common side effects of approved dermal fillers, and it has not approved injectable silicone for large-scale body contouring or enhancement. Rare but serious complications can happen if filler is accidentally injected into a blood vessel, according to FDA presentation materials, which list vision problems, tissue damage, and stroke as potential outcomes of improper technique.

Because results are temporary, patients usually need repeat treatments every eight to eighteen months to maintain their look, researchers found in a review of hyaluronic acid chin studies. That ongoing cost and upkeep is part of the trade-off patients weigh against the one-time expense and permanence of surgery.

The Broader Shift In Cosmetic Medicine

Chin filler fits into a much larger industry trend. The global medical aesthetics market is projected to approach $125 billion by 2028, driven largely by demand for procedures that offer privacy, short recovery times, and lower risk compared to traditional surgery. As more clinics promote these treatments and more patients see results on social media, the chin has become one of the most requested areas for subtle, non-surgical facial change.